Laura Marks, MD, PhD (PSTP Alumni), contributes to American Heart Association statement on injective drug use infective endocarditis (Links to an external site)

Laura Marks, MD, PhD (PSTP Alumni), contributes to American Heart Association statement on injective drug use infective endocarditis
In August 2022, the American Heart Association released a statement outlining new recommended guidelines for managing infective endocarditis in people who inject drugs, providing a timely and comprehensive approach to the management of the disease than what was previously provided by the AHA. With the incidences of infective endocarditis cases among people who inject drugs is on […]

José Saenz, MD, PhD, awarded the 2022 Young Physician Scientist Award on behalf of the ASCI

José Saenz, MD, PhD, awarded the 2022 Young Physician Scientist Award on behalf of the ASCI
Dr. José Sáenz trained as a physician-scientist at the Washington University in St. Louis School of Medicine where he learned to frame basic science questions in a broader clinical context. While his initial research interests were varied, he ultimately became drawn to microbial pathogenesis and the ability of bacteria to manage and exploit interactions with […]

Shawn Demehri, MD, PhD, elected to the ASCI

Shawn Demehri, MD, PhD, elected to the ASCI
Mass General Cancer Center physician-scientist Shawn Demehri, MD, PhD, has been elected to the American Society for Clinical Investigation (ASCI) as part of ASCI’s new class of members for 2022. Dr. Demehri is the Director for the High Risk Skin Cancer Clinic, he is a board-certified dermatologist and a principal investigator at the Center for Cancer Immunology, and Cutaneous Biology […]

Dr. Kian-Huat Lim identifies drug compound that makes pancreatic cancer cells more vulnerable to chemotherapy.

Dr. Kian-Huat Lim identifies drug compound that makes pancreatic cancer cells more vulnerable to chemotherapy.
Pancreatic cancer is extremely difficult to treat. By the time it is detected, the cancer often has reached an advanced stage, and patients usually do not survive longer than one year after diagnosis. An aggressive chemotherapy regimen is the first-line treatment, but the side effects can be severe, and many tumors stop responding to treatment. […]

Dr. Leo Shmuylovich awarded prestigious “high risk, high reward” grant

Dr. Leo Shmuylovich awarded prestigious “high risk, high reward” grant
Dr. Schmuylovich is one of four scientists at Washington University School of Medicine in St. Louis to have been awarded prestigious grants from the National Institutes of Health (NIH) aimed at supporting the researchers’ innovative and impactful biomedical and behavioral research. The grants are among a total of 106 such grants awarded to scientists recognized […]

Laura Marks, MD, PhD (PSTP Alumni), contributes to American Heart Association statement on injective drug use infective endocarditis (Links to an external site)

Laura Marks, MD, PhD (PSTP Alumni), contributes to American Heart Association statement on injective drug use infective endocarditis
In August 2022, the American Heart Association released a statement outlining new recommended guidelines for managing infective endocarditis in people who inject drugs, providing a timely and comprehensive approach to the management of the disease than what was previously provided by the AHA. With the incidences of infective endocarditis cases among people who inject drugs is on […]

José Saenz, MD, PhD, awarded the 2022 Young Physician Scientist Award on behalf of the ASCI

José Saenz, MD, PhD, awarded the 2022 Young Physician Scientist Award on behalf of the ASCI
Dr. José Sáenz trained as a physician-scientist at the Washington University in St. Louis School of Medicine where he learned to frame basic science questions in a broader clinical context. While his initial research interests were varied, he ultimately became drawn to microbial pathogenesis and the ability of bacteria to manage and exploit interactions with […]

Shawn Demehri, MD, PhD, elected to the ASCI

Shawn Demehri, MD, PhD, elected to the ASCI
Mass General Cancer Center physician-scientist Shawn Demehri, MD, PhD, has been elected to the American Society for Clinical Investigation (ASCI) as part of ASCI’s new class of members for 2022. Dr. Demehri is the Director for the High Risk Skin Cancer Clinic, he is a board-certified dermatologist and a principal investigator at the Center for Cancer Immunology, and Cutaneous Biology […]

Dr. Kian-Huat Lim identifies drug compound that makes pancreatic cancer cells more vulnerable to chemotherapy.

Dr. Kian-Huat Lim identifies drug compound that makes pancreatic cancer cells more vulnerable to chemotherapy.
Pancreatic cancer is extremely difficult to treat. By the time it is detected, the cancer often has reached an advanced stage, and patients usually do not survive longer than one year after diagnosis. An aggressive chemotherapy regimen is the first-line treatment, but the side effects can be severe, and many tumors stop responding to treatment. […]

Dr. Leo Shmuylovich awarded prestigious “high risk, high reward” grant

Dr. Leo Shmuylovich awarded prestigious “high risk, high reward” grant
Dr. Schmuylovich is one of four scientists at Washington University School of Medicine in St. Louis to have been awarded prestigious grants from the National Institutes of Health (NIH) aimed at supporting the researchers’ innovative and impactful biomedical and behavioral research. The grants are among a total of 106 such grants awarded to scientists recognized […]